BriaCell Therapeutics Corp logo

BriaCell Therapeutics Corp

NEW
FRA:8BT (Canada)   Ordinary Shares - New
€ 3 +0.18 (+6.38%) Jul 31
At Loss
P/B:
1.06
Market Cap:
€ 25.97M ($ 29.94M)
Enterprise V:
€ 5.63M ($ 6.49M)
Volume:
0
Avg Vol (2M):
763.00
Trade In:

BriaCell Therapeutics Corp (FRA:8BT) Dividend

BriaCell Therapeutics Corp (FRA:8BT) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -163.5%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:8BT Dividend

Does BriaCell Therapeutics Corp (FRA:8BT) pay a dividend?

BriaCell Therapeutics Corp (FRA:8BT) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't BriaCell Therapeutics Corp pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. BriaCell Therapeutics Corp has returned capital to shareholders via buybacks at a rate of -163.5% over the past 3 years.

What are dividend-paying alternatives to BriaCell Therapeutics Corp?

For dividend-paying alternatives in BriaCell Therapeutics Corp's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.